Review: The function of blood group-specific RBC membrane components

Immunohematology

Volumn 20, Issue 4, 2004, Pages 206-216

  Storry, Jill R ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE ANTIGEN; CARRIER PROTEIN; GLYCOPHORIN A; INTEGRIN; MEMBRANE PROTEIN; POLYSACCHARIDE;

ANTIGEN DETECTION; BLOOD GROUP SYSTEM; CAPILLARY FLOW; ERYTHROCYTE MEMBRANE; GAS EXCHANGE; HUMAN; LIFESPAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW;

BLOOD GROUP ANTIGENS; CARRIER PROTEINS; ENZYMES; ERYTHROCYTE MEMBRANE; GLYCOPROTEINS; HUMANS; MEMBRANE PROTEINS; RECEPTORS, CELL SURFACE;

EID: 10044249917     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Reid ME, Lomas-Francis C. The blood group antigen factsbook. 2nd ed. San Diego: Academic Press, 2003.
2. Daniels G. Human blood groups. 2nd ed. Oxford: Blackwell Science, 2002.
3. Reid ME, Mohandas N. RBC blood group antigens: structure and function. Semin Hematol 2004;41:93-117.
4. Moulds JM, Moulds JJ. Blood group associations with parasites, bacteria, and viruses. Transfus Med Rev 2000;14:302-11.
5. Garratty G. Blood groups and disease: a historical perspective. Transfus Med Rev 2000;14:291-301.
6. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Molecular biology of the cell. 3rd ed. New York & London: Garland Publishing, Inc, 1994.
7. Bruce LJ, Beckmann R, Ribeiro ML, et al. A band 3-based macrocomplex of integral and peripheral proteins in the RBC membrane. Blood 2003;101:4180-8.
8. Le Van Kim C, Collec E, Kroviarski Y, et al. Interaction of Kell glycoprotein with the erythroid membrane skeleton. Vox Sang 2002;83:26.
9. Kroviarski Y, El Nemer W, Gane P, et al. Direct interaction between the Lu/B-CAM adhesion glycoproteins and erythroid spectrin. Br J Haematol 2004;126:255-64.
10. An X, Guo X, Wu Y, et al. Phosphatidylserine binding sites in red cell spectrin. Blood Cells Mol Dis 2004;32:430-2.
11. An X, Guo X, Sum H, et al. Phosphatidylserine binding sites in erythroid spectrin: location and implications for membrane stability. Biochemistry 2004;43:310-5.
12. Mouro-Chanteloup I, Delaunay J, Gane P, et al. Evidence that the red cell skeleton protein 4.2 interacts with the Rh membrane complex member CD47. Blood 2003;101:338-44.
13. Nicolas V, Le Van KC, Gane P, et al. Rh-RhAG/ankyrin-R, a new interaction site between the membrane bilayer and the red cell skeleton, is impaired by Rh(null)-associated mutation. J Biol Chem 2003;278:25526-33.
14. Tanner MJ. The structure and function of band 3 (AE1): recent developments (review). Mol Membr Biol 1997;14:155-65.
15. Bruce LJ, Tanner MJ. Erythroid band 3 variants and disease. Baillieres Best Pract Res Clin Haematol 1999;12:637-54.
16. Inaba M, Yawata A, Koshino I, et al. Defective anion transport and marked spherocytosis with membrane instability caused by hereditary total deficiency of red cell band 3 in cattle due to a nonsense mutation. J Clin Invest 1996;97:1804-17.
17. Ribeiro ML, Alloisio N, Almeida H, et al. Severe hereditary spherocytosis and distal renal tubular acidosis associated with the total absence of band 3. Blood 2000;96:1602-4.
18. Southgate CD, Chishti AH, Mitchell B, et al. Targeted disruption of the murine erythroid band 3 gene results in spherocytosis and severe haemolytic anaemia despite a normal membrane skeleton. Nat Genet 1996;14:227-30.
19. Groves JD, Tanner MJ. The effects of glycophorin A on the expression of the human red cell anion transporter (band 3) in Xenopus oocytes. J Membr Biol 1994;140:81-8.
20. Bruce LJ, Groves JD, Okubo Y, et al. Altered band 3 structure and function in glycophorin A- and B-deficient (MkMk) RBCs. Blood 1994;84:916-22.
21. Bruce LJ, Pan RJ, Cope DL, et al. Altered structure and anion transport properties of band 3 (AE1, SLC4A1) in human red cells lacking glycophorin A. J Biol Chem 2004;279:2414-20.
22. Wrong O, Bruce LJ, Unwin RJ, et al. Band 3 mutations, distal renal tubular acidosis, and Southeast Asian ovalocytosis. Kidney Int 2002;62:10-9.
23. Tanner MJ. Band 3 anion exchanger and its involvement in erythrocyte and kidney disorders. Curr Opin Hematol 2002;9:133-9.
24. Cartron JP, Colin Y. Structural and functional diversity of blood group antigens. Transfus Clin Biol 2001;8:163-99.
25. Eber S, Lux SE. Hereditary spherocytosis-defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin Hematol 2004;41:118-41.
26. Avent ND, Reid ME. The Rh blood group system: a review [published erratum appears in Blood 2000 Apr 1;95(7):2197]. Blood 2000;95:375-87.
27. Avent ND, Reid ME. The Rh blood group system: a review [published erratum appears in Blood 2000 Apr 1;95(7):2197]. Blood 2000;95:375-87.
28. Huang CH. Molecular insights into the Rh protein family and associated antigens. Curr Opin Hematol 1997;4:94-103.
29. Cartron JP. RH blood group system and molecular basis of Rh-deficiency. Baillieres Best Pract Res Clin Haematol 1999;12:655-89.
30. Beckmann R, Smythe JS, Anstee DJ, et al. Functional cell surface expression of band 3, the human RBC anion exchange protein (AE1), in K562 erythroleukemia cells: band 3 enhances the cell surface reactivity of Rh antigens. Blood 1998;92:4428-38.
31. Beckmann R, Smythe JS, Anstee DJ, et al. Coexpression of band 3 mutants and Rh polypeptides: differential effects of band 3 on the expression of the Rh complex containing D polypeptide and the Rh complex containing CcEe polypeptide. Blood 2001;97:2496-505.
32. Dahl KN, Westhoff CM, Discher DE. Fractional attachment of CD47 (IAP) to the erythrocyte cytoskeleton and visual colocalization with Rh protein complexes. Blood 2003;101:1194-9.
33. Dahl KN, Parthasarathy R, Westhoff CM, et al. Protein 4.2 is critical to CD47-membrane skeleton attachment in human red cells. Blood 2004;103:1131-6.
34. Bruce LJ, Ghosh S, King MJ, et al. Absence of CD47 in protein 4.2-deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complex. Blood 2002;100:1878-85.
35. Huang CH, Liu PZ. New insights into the Rh superfamily of genes and proteins in erythroid cells and nonerythroid tissues. Blood Cells Mol Dis 2001;27:90-101.
36. Marini AM, Matassi G, Raynal V, et al. The human rhesus-associated RhAG protein and a kidney homologue promote ammonium transport in yeast. Nat Genet 2000;26:341-4.
37. Westhoff CM, Ferreri-Jacobia M, Mak DO, et al. Identification of the erythrocyte Rh blood group glycoprotein as a mammalian ammonium transporter. J Biol Chem 2002;277:12499-502.
38. Hemker MB, Cheroutre G, van Zwieten R, et al. The Rh complex exports ammonium from human RBCs. Br J Haematol 2003;122:333-40.
39. Soupene E, King N, Feild E, et al. Rhesus expression in a green alga is regulated by CO(2). Proc Natl Acad Sci U S A 2002;99:7769-73.
40. Lee S, Russo DC, Reiner AP, et al. Molecular defects underlying the Kell null phenotype. J Biol Chem 2001;20;276:27281-9.
41. Lee S, Russo D, Redman CM. The Kell blood group system: Kell and Xk membrane proteins. Semin Hematol 2000;37:113-21.
42. Russo D, Redman C, Lee S. Association of XK and Kell blood group proteins. J Biol Chem 1998;273:13950-6.
43. Danek A, Rubio JP, Rampoldi L, et al. McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol 2001;50:755-64.
44. Redman CM, Russo D, Lee S. Kell, Kx and the McLeod syndrome. Baillieres Best Pract Res Clin Haematol 1999;12:621-35.
45. Russo D, Lee S, Redman C. Intracellular assembly of Kell and XK blood group proteins. Biochim Biophys Acta 1999;1461:10-8.
46. Smith BL, Preston GM, Spring FA, et al. Human red cell aquaporin CHIP I. Molecular characterization of ABH and Colton blood group antigens. J Clin Invest 1994;94:1043-9.
47. King LS, Kozono D, Agre R From structure to disease: the evolving tale of aquaporin biology. Nature Reviews Molecular Cell Biology 2004;5:687-98.
48. Roudier N, Ripoche P, Gane P, et al. AQP3 deficiency in humans and the molecular basis of a novel blood group system, GIL. J Biol Chem 2002;277:45854-9.
49. Roudier N, Bailly P, Gane P, et al. Erythroid expression and oligomeric state of the AQP3 protein. J Biol Chem 2002;277:7664-9.
50. Olives B, Neau P, Bailly P, et al. Cloning and functional expression of a urea transporter from human bone marrow cells. J Biol Chem 1994;269:31649-52.
51. Edwards-Moulds J, Kasschau MR. Methods for the detection of Jk heterozygotes: interpretations and applications. Transfusion 1988;28:545-8.
52. Frohlich O, Macey RI, Edwards-Moulds J, et al. Urea transport deficiency in Jk(a-b-) erythrocytes. Am J Physiol 1991;260:C778-C783.
53. Macey RI, Yousef LW. Osmotic stability of red cells in renal circulation requires rapid urea transport. Am J Physiol 1988;254:C669-C674.
54. Miller LH, Mason SJ, Clyde DF, et al. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 1976;295:302-4.
55. Horuk R, Chitnis CE, Darbonne WC, et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1993;261:1182-4.
56. Chaudhuri A, Zbrzezna V, Polyakova J, et al. Expression of the Duffy antigen in K562 cells. Evidence that it is the human erythrocyte chemokine receptor. J Biol Chem 1994;269:7835-8.
57. Neote K, Mak JY, Kolakowski LF Jr., et al. Functional and biochemical analysis of the cloned Duffy antigen: identity with the RBC chemokine receptor. Blood 1994;84:44-52.
58. Yamada A, Kubo K, Takeshita T, et al. Molecular cloning of a glycosylphosphatidylinositol-anchored molecule CDw108. J Immunol 1999;162:4094-100.
59. Kikutani H, Kumanogoh A. Semaphorins in interactions between T cells and antigen-presenting cells. Nat Rev Immunol 2003;3:159-67.
60. Holmes S, Downs AM, Fosberry A, et al. Sema7A is a potent monocyte stimulator. Scand J Immunol 2002;56:270-5.
61. Cichy J, Pure E. The liberation of CD44. J Cell Biol 2003;161:839-43.
62. Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 2003;4:33-45.
63. Telen MJ. RBC surface adhesion molecules: their possible roles in normal human physiology and disease. Semin Hematol 2000;37:130-42.
64. Spring FA, Parsons SF. Erythroid cell adhesion molecules. Transfus Med Rev 2000;14:351-63.
65. Wagner FF, Poole J, Flegel WA. Scianna antigens including Rd are expressed by ERMAP. Blood 2003;101:752-7.
66. Barclay AN. Membrane proteins with immunoglobulin-like domains-a master superfamily of interaction molecules. Semin Immunol 2003;15:215-23.
67. Parsons SF, Spring FA, Chasis JA, et al. Erythroid cell adhesion molecules Lutheran and LW in health and disease. Baillieres Best Pract Res Clin Haematol 1999;12:729-45.
68. Udani M, Zen Q, Cottman M, et al. Basal cell adhesion molecule/lutheran protein. The receptor critical for sickle cell adhesion to laminin. J Clin Invest 1998;101:2550-8.
69. Zen Q, Batchvarova M, Twyman CA, et al. B-CAM/LU expression and the role of B-CAM/LU activation in binding of low- and high-density red cells to laminin in sickle cell disease. Am J Hematol 2004;75:63-72.
70. Lee G, Spring FA, Parsons SF, et al. Novel secreted isoform of adhesion molecule ICAM-4: potential regulator of membrane-associated ICAM-4 interactions. Blood 2003;101:1790-7.
71. Hermand P, Gane P, Huet M, et al. Red cell ICAM-4 is a novel ligand for platelet-activated alpha IIbbeta 3 integrin. J Biol Chem 2003;278:4892-8.
72. Lee S, Lin M, Mele A, et al. Proteolytic processing of big endothelin-3 by the Kell blood group protein. Blood 1999;94:1440-50.
73. Vaughan JI, Manning M, Warwick RM, et al. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998;338:798-803.
74. Southcott MJ, Tanner MJ, Anstee DJ. The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood 1999;93:4425-35.
75. Bony V, Gane P, Bailly P, et al. Time-course expression of polypeptides carrying blood group antigens during human erythroid differentiation. Br J Haematol 1999;107:263-74.
76. Yazdanbakhsh K, Lee S, Yu Q, et al. Identification of a defect in the intracellular trafficking of a Kell blood group variant. Blood 1999;94:310-8.
77. Spring FA, Gardner B, Anstee DJ. Evidence that the antigens of the Yt blood group system are located on human erythrocyte acetylcholinesterase. Blood 1992;80:2136-41.
78. a blood group antigen and is reduced or absent in the Yt(a-b-) phenotype. Blood 1993;81:815-9.
79. Rotundo RL. Expression and localization of acetylcholinesterase at the neuromuscular junction. J Neurocytol 2003;32:743-66.
80. ab-like antibody. Transfusion 32[8S], 19S. 1992.
81. Reid ME. The Dombrock blood group system: a review. Transfusion 2003;43:107-14.
82. Rao N, Ferguson DJ, Lee SF, et al. Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. J Immunol 1991;146:3502-7.
83. Moulds JM, Nickells MW, Moulds JJ, et al. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-Langley, and York blood group antisera. J Exp Med 1991;173:1159-63.
84. Moulds JM, Zimmerman PA, Doumbo OK, et al. Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood 2001;97:2879-85.
85. Krych-Goldberg M, Atkinson JP. Structure-function relationships of complement receptor type 1. Immunol Rev 2001;180:112-22.
86. Cockburn IA, Mackinnon MJ, O'Donnell A, et al. A human complement receptor 1 polymorphism that reduces Plasmodium falciparum resetting confers protection against severe malaria. Proc Natl Acad Sci U S A 2004;101:272-7.
87. Spring FA, Judson PA, Daniels GL, et al. A human cell-surface glycoprotein that carries Cromer-related blood group antigens on erythrocytes and is also expressed on leucocytes and platelets. Immunology 1987;62:307-13.
88. Telen MJ, Hall SE, Green AM, et al. Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF. J Exp Med 1988;167:1993-8.
89. Holmes CH, Simpson KL, Wainwright SD, et al. Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy. J Immunol 1990;144:3099-105.
90. Nowicki B, Hart A, Coyne KE, et al. Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction. J Exp Med 1993;178:2115-21.
91. Yu CY, Belt KT, Giles CM, et al. Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity. EMBO J 1986;5:2873-81.
92. Blanchong CA, Chung EK, Rupert KL, et al. Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, S1p and C4. Int Immunopharmacol 2001;1:365-92.
93. Tippett P, Storry JR, Walker PS, et al. Glycophorin A-deficient red cells may have a weak expression of C4-bound Ch and Rg antigens. Immunohematology 1996;12:4-7.
94. Colin Y. Gerbich blood groups and minor glycophorins of human erythrocytes. Transfus Clin Biol 1995;2:259-68.
95. Glinsky GV, Ivanova AB, Welsh J, et al. The role of blood group antigens in malignant progression, apoptosis resistance, and metastatic behavior. Transfus Med Rev 2000;14:326-50.
96. Issitt PD, Anstee DJ. Applied blood group serology. 4th ed. Miami, FL, USA: Montgomery Scientific Publications, 1998.
97. Roitt I, Brostoff J, Male D. Immunology. 6th ed. London: Mosby, 2001.
98. Garratty G. Blood group antigens as tumor markers, parasitic/bacterial/ viral receptors, and their association with immunologically important proteins. Immunol Invest 1995;24:213-32.